CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Feb. 03, 2018	Jan. 28, 2017	Jan. 30, 2016
Cash flows from operating activities
Net loss	$ (139,267)	$ (68,125)	$ (8,945)
Adjustments to reconcile net loss to net cash flows from operating activities:
Depreciation and amortization	42,580	44,014	43,100
Net gain on asset disposition	(275)	(846)	(2,887)
Provision for store closures and asset impairment	23,853	25,362	1,376
Stock-based compensation	4,619	8,775	2,247
Provision (recovery) for uncollectible receivables	(241)	(919)	166
LIFO reserve increase	1,278	5,091	7,545
Deferred income tax benefit	(2,083)	(7,772)	(831)
Amortization of debt issuance costs	273	105	154
Benefit for postretirement medical	(1)	(55)	(45)
(Increase) decrease in operating assets:
Trade and non-trade receivables	3,650	987	(3,570)
Insurance receivables	276	(69)	(301)
Inventories	28,949	(11,639)	(30,351)
Other assets	6,983	595	2,945
Increase (decrease) in operating liabilities:
Accounts payable and accrued expenses	5,083	(27,964)	32,938
Income taxes receivable	(5)	7,175	8,432
Other noncurrent liabilities	5,907	(2,842)	(2,261)
Net cash provided by (used in) operating activities of continuing operations	(18,421)	(28,127)	49,712
Cash flows from investing activities of continuing operations:
Capital expenditures	(15,753)	(23,940)	(22,800)
Proceeds from asset dispositions	2,206	2,619	3,747
Insurance recoveries for replacement assets	119	416
Asset acquisitions, net (primarily intangibles)	(1,718)	(12,700)	(16,596)
Acquisition of Reeves-Sain Drug Store, Inc., net of cash			9,122
Net cash used in investing activities of continuing operations	(15,146)	(33,605)	(26,527)
Cash flows from financing activities of continuing operations:
Payments of indebtedness and capital lease obligations	(59)	(621)	(554)
Proceeds from revolving line of credit	910,181	990,965	937,164
Payments on revolving line of credit	(871,081)	(914,962)	(902,681)
Debt issuance costs	(597)	(5,831)	(525)
Proceeds (payments) from exercise of stock options and employee stock purchase plan	(39)	553	2,462
(Distributions to)/contribution from subsidiary	7,727	510	(50,645)
Repurchase of shares	(4,975)
Cash dividends paid	(6,847)	(8,969)	(8,929)
Net cash provided by (used in) financing activities of continuing operations	34,310	61,645	(23,708)
Increase/(decrease) in cash and cash equivalents	743	(87)	(523)
Cash flow from discontinued operations
Cash flows from operating activities of discontinued operations, net	8,547	1,022	1,388
Cash flows from investing activities of discontinued operations, net	(820)	(512)	(52,033)
Cash flows from financing activities of discontinued operations, net	(7,727)	(510)	50,645
Net increase (decrease) in cash and cash equivalents	743	(87)	(523)
Cash and cash equivalents, beginning of year	5,830	5,917	6,440
Cash and cash equivalents of discontinued operations/held for sale operations, beginning of year
Net increase (decrease) in cash and cash equivalents	743	(87)	(523)
Less: cash and cash equivalents of discontinued/held for sale operations at end of year
Cash and cash equivalents, end of year	6,573	5,830	5,917
Supplemental disclosures of cash flow information:
Interest paid	6,297	2,318	1,431
Income taxes refunded	(1,721)	(9,906)	(12,911)
Non-cash investing and financial activities:
Acquisition related note payable, see Note 4 - Indebtedness			$ 13,000